全文获取类型
收费全文 | 2033篇 |
免费 | 153篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 90篇 |
妇产科学 | 27篇 |
基础医学 | 324篇 |
口腔科学 | 33篇 |
临床医学 | 176篇 |
内科学 | 449篇 |
皮肤病学 | 79篇 |
神经病学 | 95篇 |
特种医学 | 199篇 |
外国民族医学 | 1篇 |
外科学 | 191篇 |
综合类 | 67篇 |
一般理论 | 1篇 |
预防医学 | 173篇 |
眼科学 | 18篇 |
药学 | 137篇 |
中国医学 | 5篇 |
肿瘤学 | 111篇 |
出版年
2022年 | 16篇 |
2021年 | 36篇 |
2020年 | 28篇 |
2019年 | 42篇 |
2018年 | 51篇 |
2017年 | 38篇 |
2016年 | 41篇 |
2015年 | 46篇 |
2014年 | 57篇 |
2013年 | 87篇 |
2012年 | 89篇 |
2011年 | 89篇 |
2010年 | 76篇 |
2009年 | 100篇 |
2008年 | 87篇 |
2007年 | 79篇 |
2006年 | 64篇 |
2005年 | 87篇 |
2004年 | 57篇 |
2003年 | 50篇 |
2002年 | 52篇 |
2001年 | 48篇 |
2000年 | 42篇 |
1999年 | 45篇 |
1998年 | 46篇 |
1997年 | 45篇 |
1996年 | 45篇 |
1995年 | 43篇 |
1994年 | 29篇 |
1993年 | 29篇 |
1992年 | 28篇 |
1991年 | 28篇 |
1990年 | 24篇 |
1989年 | 47篇 |
1988年 | 39篇 |
1987年 | 30篇 |
1986年 | 35篇 |
1985年 | 24篇 |
1984年 | 30篇 |
1983年 | 29篇 |
1982年 | 29篇 |
1981年 | 20篇 |
1980年 | 26篇 |
1979年 | 16篇 |
1978年 | 21篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 14篇 |
1974年 | 14篇 |
1968年 | 9篇 |
排序方式: 共有2194条查询结果,搜索用时 9 毫秒
31.
Prada Diddier Baccarelli Andrea A. Terry Mary Beth Valdéz Leonora Cabrera Paula Just Allan Kloog Itai Caro Haydee García-Cuellar Claudia Sánchez-Pérez Yesennia Cruz Rodrigo Diaz-Chávez Jose Cortés Carlo Pérez Delia Meneses-García Abelardo Cantú-de-León David Herrera Luis A. Bargalló Enrique 《Breast cancer research and treatment》2021,187(2):525-533
Breast Cancer Research and Treatment - Many patients seek breast reconstruction following mastectomy. Debate exists regarding the best reconstructive option. The authors evaluate outcomes comparing... 相似文献
32.
Fabián Matías Caro María Laura Alberti Federico Campins Juan Ignacio Enghelmayer Martín Eduardo Fernández Diana Lancellotti Tulio Papucci Javier Adrián Sebastiani Francisco Paulin 《Archivos de bronconeumologia》2019,55(2):75-80
Introduction
Pirfenidone was the first antifibrotic drug approved in Argentina for idiopathic pulmonary fibrosis (IPF). Outcomes in real life may differ from the results of clinical trials. The primary endpoint was to study the tolerance of pirfenidone in real life. Secondary endpoints were to analyze effectiveness and reasons for discontinuation.Materials and methods
Retrospective observational study conducted in four specialized centers in Argentina. We analyzed the medical records of patients with IPF who received pirfenidone between June 2013 and September 2016. Adverse events (AE) and the variables that could influence these results were analyzed. Forced vital capacity (FVC%) parameters were also compared between the pre-pirfenidone and post-pirfenidone periods.Results
Fifty patients were included, 38 (76%) men, with mean age (SD) 67.8 (8.36) years. Mean (SD) exposure to pirfenidone was 645.68 (428.19) days, with a mean daily dose (SD) of 2064.56 mg (301.49). Nineteen AEs in 15 patients (30%) were reported: nausea (14%), asthenia (10%) and skin rash (8%). A total of 18 patients (36%) interrupted treatment, only 1 definitively. The most frequent reason for discontinuation was failure of suppliers to provide the drug (9 subjects; 18%). We compared the evolution of FVC% between the pre-pirfenidone and post-pirfenidone periods, and found a mean (SD) FVC% decline of 4.03% (7.63) pre-pirfenidone and 2.64% (7.1) post-pirfenidone (P=.534).Conclusions
In our study, pirfenidone was well tolerated and associated with a reduction in FVC decline, although without reaching statistical significance. 相似文献33.
34.
H Khalili A Soudbakhsh M Hajiabdolbaghi S Dashti-Khavidaki A Poorzare AA Saeedi R Sharififar 《BMC infectious diseases》2008,8(1):165
Background
Human immunodeficiency virus infected individuals are prone to malnutrition due to increased energy requirements, enteropathy and increased catabolism. Trace elements such as zinc and selenium have major role in maintaining a healthy immune system. This study was designed to evaluate the nutritional status of Iranian subjects who were newly diagnosed with human immunodeficiency virus infection and to compare serum level of zinc and selenium in these patients with those of the sex and aged match healthy subjects. 相似文献35.
36.
背景目前已开展了对重性精神病患者进提供连续性服务的研究。目的探讨基层对有抑郁症风险患者提供连续性服务的水平,并与对心力衰竭患者的服务水平进行对比。方法采用抑郁症风险患者与心力衰竭患者对比的探索性研究。采用患者问卷评估服务的持续性,包含如下内容:(1)联系的服务提供者数(个人连续性);(2)诊所内服务提供者之间的合作(团队连续性)(6个项目,分数1~5分);(3)诊所外全科医师与服务提供者之间的合作(跨界连续性)(4个项目,分数1~5分)。结果大多数抑郁症风险患者在过去1年中寻遍整个服务提供界联系了几个服务提供者,曾遇到过高水平团队连续性服务及低水平跨界连续性服务。在诊所中可接触到的不同服务提供者要明显多于心力衰竭患者服务提供者(P<0.01)。抑郁症风险患者的服务提供者之间的合作更好一些,每项平均得分4.3分,心力衰竭患者得分为4.0分(P=0.03)。然而,跨界连续性服务方面正好相反:抑郁症风险患者每项平均得分3.5分,心力衰竭患者得分为4.0分(P=0.01)。结论抑郁症风险患者与心力衰竭患者之间的探索性对比显示:体验服务连续性方面的差距不大。对此还应行进一步分析。 相似文献
37.
Jaime Caro Alexandra Ward Jorgen Moller 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2006,8(6):449-455
AIMS: To estimate the consequences of managing bradycardia due to sinoatrial node disease or atrioventricular block with dual-chamber vs. single-chamber ventricular pacemakers. METHODS AND RESULTS: A discrete-event simulation was conducted to predict outcomes over 5 years. Patients could develop post-operative complications, clinically relevant pacemaker syndrome leading to replacement of single-chamber with dual-chamber, atrial fibrillation (AF; which if chronic might require anticoagulants) or stroke. Survival, quality-adjusted life years (QALYs), complications, and associated direct medical costs were estimated (2003 British Pounds pounds sterling). Identical patients were simulated after receiving a single-chamber device or a more expensive dual-chamber pacemaker. Probabilities of conditions were obtained from clinical trials. Benefits were discounted at 1.5% and costs at 6%. Post-operative complications increased from 6.4% with single-chamber to 7.7% with dual-chamber but AF decreased (22 vs. 18%) as did clinically relevant pacemaker symptoms (16.8 vs. 0%). Approximately 4300 pounds sterling were accrued per patient over 5 years. Additional health benefits with dual-chamber are achieved at a mean net cost of 43 pounds sterling per patient, leading to 0.09 QALY with a cost-effectiveness ratio of 477 pounds sterling/QALY. CONCLUSION: Implanting the costlier device increases the cost of the initial operation; however, this is expected to be offset by a reduction in costs associated with re-operations and AF. 相似文献
38.
P.A. Caro Aponte C.A. Otálora J.C. Guzmán L.F. Turner J.P. Alcázar E.L. Mayorga 《Neurología (Barcelona, Spain)》2021,36(3):191-200
Parkinson's disease (PD) is characterised by motor alterations, which are commonly treated with L-DOPA. However, long-term L-DOPA use may cause dyskinesia. Although the pathogenic mechanism of L-DOPA-induced dyskinesia is unclear, the condition has been associated with alterations in dopamine receptors, among which D2 receptors (D2R) have received little attention. This study aims to: (i) develop and standardise an experimental model of L-DOPA-induced dyskinesia in rats with hemiparkinsonism; and (ii) evaluate the correlation between D2R expression and presence of abnormal involuntary movements (AIM). We allocated 21 male Wistar rats into 3 groups: intact controls, lesioned rats (with neurotoxin 6-OHDA), and dyskinetic rats (injected with L-DOPA for 19 days). Sensorimotor impairment was assessed with behavioural tests. Dyskinetic rats gradually developed AIMs during the treatment period; front leg AIMs were more severe and locomotor AIMs less severe (P < .05). All AIMs were significantly evident from day 5 and persisted until the last day of injection. D2R density was greater in the striatum and the medial anterior brain of the lesioned and dyskinetic rats than in those of controls. Our results suggest an association between D2R expression and locomotor AIMs. We conclude that RD2 is involved in L-DOPA-induced dyskinesia. 相似文献
39.
N. Berthet S. Paulous L.L. Coffey M.P. Frenkiel I. Moltini C. Tran S. Matheus C. Ottone M.N. Ungeheuer C. Renaudat V. Caro P. Dussart A. Gessain P. Desprès 《Journal of clinical virology》2013,56(3):322-327
BackgroundResequencing DNA microarray (RMA) technology uses probes designed to identify a panel of viral sequences. It can be used for detecting emerging viruses by revealing the nucleotide polymorphisms within the target of interest.Objectives/study designAs a new tool for molecular diagnosis of arbovirus infection, high density PathogenID v2.0 RMA (PID2-RMA) was assessed for the detection and genetic analysis of dengue, West Nile, and Chikungunya viruses in spiked blood samples or sera from individuals infected with dengue virus. Viral RNAs extracted from biological samples were retrotranscribed into cDNA and amplified using the Phi 29 polymerase-based method. This amplified cDNA was used for hybridization on PID2-RMA.ResultsA good specificity of RMA-based detection was demonstrated using a panel of arboviruses including Dengue, West Nile and Chikungunya viruses. This technology was also efficient for the detection and genetic analysis of the different serotypes of dengue virus in sera of infected patients. Furthermore, the mixing of dengue, West Nile and Chikungunya prototype viruses within a single sample of human blood did not interfere with the sensitivity of PID2-RMA.ConclusionsOur data show that high density PID2-RMA was suitable for the identification of medically important arboviruses. It appears to be particularly adapted to the genetic analysis of dengue, West Nile, and Chikungunya viruses in urgent clinical situations where the rapid identification and characterization of the pathogen is essential. 相似文献
40.